Tissue type is a major modifier of the 5-hydroxymethylcytosine content of human genes

Genome Research

Volumn 22, Issue 3, 2012, Pages 467-477

  Nestor, Colm E ^a,b   Ottaviano, Raffaele ^a,b   Reddington, James ^b   Sproul, Duncan ^a,b   Reinhardt, Diana ^b   Dunican, Donncha ^b   Katz, Elad ^a   Dixon, J Michael ^a   Harrison, David J ^a   Meehan, Richard R ^a,b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYMETHYLCYTOSINE; DNA;

ARTICLE; CANCER CELL; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE EXPRESSION; GENE LOCUS; GENE MAPPING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TISSUE SPECIFICITY;

ANIMALS; CELL LINE; CELLS, CULTURED; CHROMOSOME MAPPING; CLUSTER ANALYSIS; CYTOSINE; DNA; DNA METHYLATION; EMBRYONIC STEM CELLS; EPIGENESIS, GENETIC; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC LOCI; HUMANS; MICE; NUCLEAR PROTEINS; ORGAN SPECIFICITY; PROMOTER REGIONS, GENETIC; TRANSCRIPTION, GENETIC;

MAMMALIA;

EID: 84857891830     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.126417.111     Document Type: Article

References (50)

1. Aflatoonian B, Ruban L, Shamsuddin S, Baker D, Andrews P, Moore H. 2010. Generation of Sheffield (Shef) human embryonic stem cell lines using a microdrop culture system. In Vitro Cell Dev Biol Anim 46: 236-241.
2. Bird A. 2002. DNA methylation patterns and epigenetic memory. Genes Dev 16: 6-21. (Pubitemid 34049633)
3. Borgel J, Guibert S, Li Y, Chiba H, Schubeler D, Sasaki H, Forne T, Weber M. 2010. Targets and dynamics of promoter DNA methylation during early mouse development. Nat Genet 42: 1093-1100.
4. Chen DT, Nasir A, Culhane A, Venkataramu C, Fulp W, Rubio R, Wang T, Agrawal D, McCarthy SM, Gruidl M, et al. 2010. Proliferative genes dominate malignancy-risk gene signature in histologically-normal breast tissue. Breast Cancer Res Treat 119: 335-346.
5. Cleveland W. 1979. Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc 74: 829-836.
6. Dahl C, Gronbaek K, Guldberg P. 2011. Advances in DNA methylation: 5-hydroxymethylcytosine revisited. Clin Chim Acta 412: 831-836.
7. Davis T, Vaisvila R. 2011. High sensitivity 5-hydroxymethylcytosine detection in Balb/C brain tissue. J Vis Exp e2661. doi: 10.3791/2661.
8. Ehrlich M, Gama-Sosa MA, Huang LH, Midgett RM, Kuo KC, McCune RA, Gehrke C. 1982. Amount and distribution of 5-methylcytosine in human DNA from different types of tissues of cells. Nucleic Acids Res 10: 2709-2721.
9. Esteller M. 2007. Cancer epigenomics: DNA methylomes and histonemodification maps. Nat Rev Genet 8: 286-298. (Pubitemid 46439286)
10. Ficz G, Branco MR, Seisenberger S, Santos F, Krueger F, Hore TA, Marques CJ, AndrewsS, ReikW. 2011.Dynamic regulationof5-hydroxymethylcytosine in mouse ES cells and during differentiation. Nature 473: 398-402.
11. Figueroa ME, Abdel-Wahab O, Lu C, Ward PS, Patel J, Shih A, Li Y, Bhagwat N, Vasanthakumar A, Fernandez HF, et al. 2010. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell 18: 553-567.
12. Globisch D, Munzel M, Muller M,Michalakis S,Wagner M, Koch S, Bruckl T, Biel M, Carell T. 2010. Tissue distribution of 5-hydroxymethylcytosine and search for active demethylation intermediates. PLoS ONE 5: e15367. doi: 10.1371/journal.pone.0015367.
13. Hajkova P, Erhardt S, Lane N, Haaf T, El-Maarri O, Reik W, Walter J, Surani MA. 2002. Epigenetic reprogramming in mouse primordial germ cells. Mech Dev 117: 15-23. (Pubitemid 36158711)
14. Holliday DL, Brouilette KT, Markert A, Gordon LA, Jones JL. 2009. Novel multicellular organotypic models of normal and malignant breast: tools for dissecting the role of the microenvironment in breast cancer progression. Breast Cancer Res 11: R3. doi: 10.1186/bcr2218.
15. Huang Y, Pastor WA, Shen Y, Tahiliani M, Liu DR, Rao A. 2010. The behaviour of 5-hydroxymethylcytosine in bisulfite sequencing. PLoS ONE 5: e8888. doi: 10.1371/journal.pone.0008888.
16. Iqbal K, Jin SG, Pfeifer GP, Szabo PE. 2011. Reprogramming of the paternal genome upon fertilization involves genome-wide oxidation of 5-methylcytosine. Proc Natl Acad Sci 108: 3642-3647.
17. Ito S, D'Alessio AC, Taranova OV, Hong K, Sowers LC, Zhang Y. 2010. Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature 466: 1129-1133.
18. Jin SG, Kadam S, Pfeifer GP. 2010. Examination of the specificity of DNA methylation profiling techniques towards 5-methylcytosine and 5-hydroxymethylcytosine. Nucleic Acids Res 38: e125. doi: 10.1093/nar/ gkq223.
19. Jin SG, Wu X, Li AX, Pfeifer GP. 2011. Genomic mapping of 5-hydroxymethylcytosine in the human brain. Nucleic Acids Res 39: 5015-5024.
20. Kinney SM, Chin HG, Vaisvila R, Bitinaite J, Zheng Y, Esteve PO, Feng S, Stroud H, Jacobsen SE, Pradhan S. 2011. Tissue-specific distribution and dynamic changes of 5-hydroxymethylcytosine in mammalian genomes. J Biol Chem 286: 24685-24693.
21. Koh KP, Yabuuchi A, Rao S, Huang Y, Cunniff K, Nardone J, Laiho A, Tahiliani M, Sommer CA, Mostoslavsky G, et al. 2011. Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells. Cell Stem Cell 8: 200-213.
22. Kriaucionis S, Heintz N. 2009. ThenuclearDNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 324: 929-930.
23. Li E, Bestor TH, Jaenisch R. 1992. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69: 915-926.
24. Lock LF, Takagi N, Martin GR. 1987. Methylation of the Hprt gene on the inactive X occurs after chromosome inactivation. Cell 48: 39-46.
25. Lorsbach RB, Moore J, Mathew S, Raimondi SC, Mukatira ST, Downing JR. 2003. TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23). Leukemia 17: 637-641. (Pubitemid 36395661)
26. Mayer W, Niveleau A, Walter J, Fundele R, Haaf T. 2000. Demethylation of the zygotic paternal genome. Nature 403: 501-502. (Pubitemid 30082186)
27. Nestor C, Ruzov A, Meehan R, Dunican D. 2010. Enzymatic approaches and bisulfite sequencing cannot distinguish between 5-methylcytosine and 5-hydroxymethylcytosine in DNA. Biotechniques 48: 317-319.
28. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, Clark L, Bayani N, Coppe JP, Tong F, et al. 2006. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10: 515-527. (Pubitemid 44854747)
29. Ohm JE, McGarvey KM, Yu X, Cheng L, Schuebel KE, Cope L, Mohammad HP, Chen W, Daniel VC, Yu W, et al. 2007. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet 39: 237-242.
30. Oswald J, Engemann S, Lane N, Mayer W, Olek A, Fundele R, Dean W, Reik W, Walter J. 2000. Active demethylation of the paternal genome in the mouse zygote. Curr Biol 10: 475-478. (Pubitemid 30247337)
31. Pastor WA, Pape UJ, Huang Y, Henderson HR, Lister R, Ko M, McLoughlin EM, Brudno Y, Mahapatra S, Kapranov P, et al. 2011. Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells. Nature 473: 394-397.
32. Plass C, Soloway PD. 2002. DNA methylation, imprinting and cancer. Eur J Hum Genet 10: 6-16. (Pubitemid 34229046)
33. Ramskold D, Wang ET, Burge CB, Sandberg R. 2009. An abundance of ubiquitously expressed genes revealed by tissue transcriptome sequence data. PLoS Comput Biol 5: e1000598. doi: 10.1371/journal.pcbi.1000598.
34. Richardson AL, Wang ZC, De Nicolo A, Lu X, Brown M, Miron A, Liao X, Iglehart JD, Livingston DM, Ganesan S. 2006. X chromosomal abnormalities in basal-like human breast cancer. Cancer Cell 9: 121-132. (Pubitemid 43202662)
35. Sado T, Fenner MH, Tan SS, TamP, Shioda T, Li E. 2000. X inactivation in the mouse embryo deficient for Dnmt1: Distinct effect of hypomethylation on imprinted and random X inactivation. Dev Biol 225: 294-303.
36. Song CX, Szulwach KE, Fu Y, Dai Q, Yi C, Li X, Li Y, Chen CH, ZhangW, Jian X, et al. 2010. Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine. Nat Biotechnol 29: 68-72.
37. Sproul D, Nestor C, Culley J, Dickson JH, Dixon JM, Harrison DJ, Meehan RR, Sims AH, Ramsahoye BH. 2011. Transcriptionally repressed genes become aberrantly methylated and distinguish tumors of different lineages in breast cancer. Proc Natl Acad Sci 108: 4364-4369.
38. Szwagierczak A, Bultmann S, Schmidt CS, Spada F, Leonhardt H. 2010. Sensitive enzymatic quantification of 5-hydroxymethylcytosine in genomic DNA. Nucleic Acids Res 38: e181. doi: 10.1093/nar/gkq684.
39. Tahiliani M, Koh KP, Shen Y, PastorWA, Bandukwala H, Brudno Y, Agarwal S, Iyer LM, Liu DR, Aravind L, et al. 2009. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324: 930-935.
40. Turashvili G, Bouchal J, Baumforth K,WeiW,Dziechciarkova M, Ehrmann J, Klein J, Fridman E, Skarda J, Srovnal J, et al. 2007. Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis. BMC Cancer 7: 55. doi: 10.1186/1471-2407-7-55.
41. Valinluck V, Sowers LC. 2007. Endogenous cytosine damage products alter the site selectivity of human DNA maintenance methyltransferase DNMT1. Cancer Res 67: 946-950.
42. Valinluck V, Tsai HH, Rogstad DK, Burdzy A, Bird A, Sowers LC. 2004. Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2). Nucleic Acids Res 32: 4100-4108. (Pubitemid 39232282)
43. Walsh CP, Chaillet JR, Bestor TH. 1998. Transcription of IAP endogenous retroviruses is constrained by cytosine methylation. Nat Genet 20: 116-117. (Pubitemid 28455441)
44. Weisenberger DJ, Campan M, Long TI, Kim M,Woods C, Fiala E, Ehrlich M, Laird PW. 2005. Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res 33: 6823-6836. (Pubitemid 41830488)
45. Williams K, Christensen J, Pedersen MT, Johansen JV, Cloos PA, Rappsilber J, Helin K. 2011. TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity. Nature 473: 343-348.
46. Wossidlo M, Nakamura T, Lepikhov K, Marques CJ, Zakhartchenko V, Boiani M, Arand J, Nakano T, ReikW,Walter J. 2011. 5-Hydroxymethylcytosine in themammalian zygote is linked with epigenetic reprogramming. Nat Commun 2: 241. doi: 10.1038/ncomms1240.
47. Wu SC, Zhang Y. 2010. Active DNA demethylation: Many roads lead to Rome. Nat Rev Mol Cell Biol 11: 607-620.
48. Wu H, D'Alessio AC, Ito S,Wang Z, Cui K, Zhao K, Sun YE, Zhang Y. 2011a. Genome-wide analysis of 5-hydroxymethylcytosine distribution reveals its dual function in transcriptional regulation in mouse embryonic stem cells. Genes Dev 25: 679-684.
49. Wu H, D'Alessio AC, Ito S, Xia K, Wang Z, Cui K, Zhao K, Sun YE, Zhang Y. 2011b. Dual functions of Tet1 in transcriptional regulation in mouse embryonic stem cells. Nature 473: 389-393.
50. Xu W, Yang H, Liu Y, Yang Y,Wang P, Kim SH, Ito S, Yang C, Xiao MT, Liu LX, et al. 2011.Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of a-ketoglutarate-dependent dioxygenases. Cancer Cell 19: 17-30.